Regulus Therapeutics
RGLS
#9181
Rank
C$0.12 B
Marketcap
$1.86
Share price
-9.72%
Change (1 day)
-51.59%
Change (1 year)

Regulus Therapeutics (RGLS) - Net assets

Net assets on the balance sheet as of December 2024 : C$0.10 Billion

According to Regulus Therapeutics's latest financial reports the company has C$0.10 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Regulus Therapeutics - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$C$0.10 B290.17%
2023-12-31$C$28.1 M-37.79%
2022-12-31$C$45.17 M-35.5%
2021-12-31$C$70.04 M111.06%
2020-12-31$C$33.18 M26.95%
2019-12-31$C$26.14 M-427.81%
2018-12-31$-C$7.98 Million-118.01%
2017-12-31$C$44.27 M-41.25%
2016-12-31$C$75.35 M-56.22%
2015-12-31$C$0.17 B12.35%
2014-12-31$C$0.15 B53.99%
2013-12-31$C$99.48 M61.12%
2012-12-31$C$61.74 M-246.29%
2011-12-31$-C$42.21 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$23.47 B 21,392.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$115.81 B 105,934.97%๐Ÿ‡ซ๐Ÿ‡ท France
C$23.89 B 21,777.29%๐Ÿ‡บ๐Ÿ‡ธ USA
C$58.42 B 53,390.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$95.9 M-12.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$32.54 M-70.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$23.42 B 21,348.02%๐Ÿ‡บ๐Ÿ‡ธ USA